Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Effective management of hyperandrogenism in young women requires accurate diagnosis and tailored treatment.

Non-classical 21-hydroxylase deficiency can be missed in newborn screenings and should be considered in cases of early puberty or virilization.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Hyperthyroidism can hide signs of high androgen levels in females.

Postmenopausal women with unusual hair growth should be checked for ovarian tumors.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

Androgenetic alopecia is a common genetic and hormonal hair loss affecting many men and women.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

A woman with non-classic CAH had unusual heavy periods and high hormone levels, improved with treatment.